glp 1 asa guidelines 🔸 Should GLP-1 RAs be continued preprocedurally? 🔸 Who should stop a GLP-1 RA preoperatively? 🔸 Which patients should have their procedures postponed? Read: https://doi.org/10.1097/01.ASM.0001125664.22893.9f Frontiers | Mechanisms of action

Planning for potential coverage disruptions by identifying compounded alternatives in advance prevents forced abrupt discontinuation

Important safety considerations during the initial treatment period include: Monitoring for severe gastrointestinal symptoms: Persistent vomiting, severe abdominal pain, or signs of pancreatitis (severe upper abdominal pain radiating to the back) require immediate medical evaluation

Public health systems in developed markets are establishing structured access pathways based on BMI thresholds combined with cardiovascular or metabolic comorbidities

1 This translates into a lower risk of hypoglycemia compared to other diabetes treatment options like sulfonylureas and insulin